(0.51%) 5 214.08 points
(0.85%) 39 388 points
(0.27%) 16 346 points
(0.52%) $79.67
(0.48%) $2.31
(0.61%) $2 354.60
(0.86%) $28.61
(0.23%) $993.10
(0.00%) $0.927
(-0.16%) $10.85
(-0.02%) $0.798
(0.00%) $92.54
4.70% $ 24.93
@ $22.91
Emitido: 8 feb 2024 @ 12:13
Retorno: 8.82%
Señal anterior: feb 7 - 15:54
Señal anterior:
Retorno: -4.78 %
Live Chart Being Loaded With Signals
Dianthus Therapeutics, Inc. operates as a clinical-stage biotechnology company that designs, develops, and delivers novel monoclonal antibodies for people living with severe autoimmune and inflammatory diseases...
Stats | |
---|---|
Volumen de hoy | 70 016.00 |
Volumen promedio | 167 609 |
Capitalización de mercado | 731.62M |
EPS | $0 ( 2024-03-21 ) |
Próxima fecha de ganancias | ( $-0.430 ) 2024-06-20 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -2.95 |
ATR14 | $0.0760 (0.30%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-01 | Fairmount Funds Management Llc | Buy | 58 857 | Common Stock |
2024-04-01 | Fairmount Funds Management Llc | Sell | 58 857 | Common Stock |
2024-01-24 | Carr Edward | Buy | 80 000 | Stock Option (Right to Buy) |
2024-01-24 | Veness Adam M | Buy | 110 000 | Stock Option (Right to Buy) |
2024-01-24 | Randhawa Simrat | Buy | 120 000 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
97.86 |
Last 18 transactions |
Buy: 6 045 948 | Sell: 58 857 |
Volumen Correlación
Dianthus Therapeutics, Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Dianthus Therapeutics, Correlación - Moneda/Commodity
Dianthus Therapeutics, Finanzas
Annual | 2023 |
Ingresos: | $2.83M |
Beneficio Bruto: | $2.47M (87.44 %) |
EPS: | $-8.45 |
FY | 2023 |
Ingresos: | $2.83M |
Beneficio Bruto: | $2.47M (87.44 %) |
EPS: | $-8.45 |
FY | 2022 |
Ingresos: | $6.42M |
Beneficio Bruto: | $6.27M (97.71 %) |
EPS: | $-32.57 |
Financial Reports:
No articles found.
Dianthus Therapeutics,
Dianthus Therapeutics, Inc. operates as a clinical-stage biotechnology company that designs, develops, and delivers novel monoclonal antibodies for people living with severe autoimmune and inflammatory diseases. It develops DNTH103 that is in phase 1 clinical trails in patients with generalized myasthenia gravis, multifocal motor neuropathy, and chronic inflammatory demyelinating polyneuropathy. Dianthus Therapeutics, Inc. was incorporated in 2015 and is based in New York, New York.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico